Comments are Off
IID2013, Investigative Dermatology, NativeSkin
We are very pleased to announce that our technology NativeSkin will be presented in a nice study done by LEO Pharma and us at the International Investigative Dermatology annual meeting.
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
Shop – Europe & Middle-East
Shop – Asia & Pacific
Shop – United States & Canada
Genoskin launches the ISR platform®
6 July 2021
Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals
15 June 2021
Injection site reactions platform
10 June 2021
Interview with Pr. Guy Serre
9 June 2021